Cagrilintide Prices in 2026: What Research Vendors Are Charging

Cagrilintide has become one of the most requested peptides in the research market this year. As Novo Nordisk continues advancing this long-acting amylin analog through clinical trials, researchers studying metabolic pathways and satiety signaling have driven demand through the roof. That demand is showing up in vendor pricing, and the landscape is more varied than you might expect.

The Current Price Range

Research-grade cagrilintide is sitting in a wide pricing band right now. At the lower end, some vendors are offering 5mg vials for around $45 to $60. Premium suppliers with extensive third-party testing documentation are charging $90 to $120 for the same quantity.

That spread tells you something important: this market is still maturing.

The peptide itself is relatively complex to synthesize compared to simpler research compounds. It requires specific modifications to extend its half-life, which adds manufacturing steps and costs. Vendors with established synthesis pipelines can offer better prices. Newer entrants are charging more to cover their development overhead.

Why Prices Vary So Much

Three factors are driving the pricing differences you'll see across vendors:

Purity verification. Vendors providing HPLC and mass spectrometry reports from independent labs build those testing costs into their prices. You're paying for documentation, not just the compound.

Batch size economics. Larger vendors synthesizing bigger batches can spread fixed costs across more units. Smaller operations ordering from contract manufacturers face higher per-unit costs.

Geographic sourcing. Synthesis location matters. US-based production typically commands higher prices than overseas manufacturing, though quality can be equivalent with proper quality control.

Market Trends Worth Watching

Cagrilintide prices have actually dropped about 15% over the past six months. More vendors have entered the space, and synthesis methods have become more standardized. Competition is doing what competition does.

That said, don't expect dramatic further drops soon. The compound's complexity creates a price floor that simpler peptides don't have. And ongoing pharmaceutical interest keeps research demand steady.

One development to track: some vendors now offer cagrilintide in combination research kits alongside semaglutide analogs. This mirrors the pharmaceutical direction Novo Nordisk is pursuing with CagriSema. These bundles sometimes offer better per-compound pricing than buying separately.

What This Means for You

If you're sourcing cagrilintide for research, price comparison matters more here than with many other peptides. The spread between vendors is significant enough that checking multiple sources can save you 30% or more on identical purity material.

Don't automatically grab the cheapest option. Look for vendors who provide batch-specific testing documentation. A $50 vial with no purity data isn't necessarily better than a $90 vial with verified 98%+ purity.

Compare current cagrilintide pricing from verified vendors at /prices/cagrilintide, or browse supplier reviews at /vendors to find sources that match your research requirements and budget.